Roche Holding AG Stock
Your prediction
Roche Holding AG Stock
There is an upward development for Roche Holding AG compared to yesterday, with an increase of €5.60 (1.460%).
Pros and Cons of Roche Holding AG in the next few years
Pros
?
B****
?
S********** s********
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Roche Holding AG vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Roche Holding AG | 1.460% | 0.051% | 6.291% | 32.900% | 6.876% | 57.967% | 57.967% |
| Beximco Pharmaceuticals Ltd. GDR | 0.950% | 3.922% | 17.778% | 23.832% | 18.304% | 38.021% | -39.773% |
| Eledon Pharmaceuticals Inc. | -2.760% | -10.759% | -15.060% | 10.156% | 120.313% | 141.026% | -48.257% |
| SELLAS Life Sciences Group Inc | -2.910% | -12.851% | -32.973% | 520.887% | 206.173% | 479.439% | 20.556% |
Comments
News
Madrigal Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Madrigal Pharmaceuticals, Inc.? Here are five stocks we like better.
- Rezdiffra sales rose 71% year over year to $364.3 million in Q2 2026, with nearly $1.3 billion in
Alnylam Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Alnylam Pharmaceuticals, Inc.? Here are five stocks we like better.
- Second-quarter revenue surged 74% to approximately $1.2 billion, driven by AMVUTTRA, which
The Hanover Insurance Group Q2 Earnings Call Highlights
The Hanover Insurance Group (NYSE:THG) reported record second-quarter operating performance, citing improved underwriting margins, accelerating premium growth and higher investment income across